信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·收评：沪指跌1.52％，北向资金净卖出近80亿元，医药股逆势活跃2023-5-23 15:11:23
·午评：沪指盘中跳水跌0.58％，新冠药物概念大涨，中字头板块低迷2023-5-23 11:39:02
·2023年5月第三周创新药周报（附小专题2023ASCO国产新药汇总）2023-5-23 10:37:10
·众生药业：钟南山院士为来瑞特韦片III期临床研究的总PI2023-5-23 9:50:35
·基础化工行业周报：碳酸锂价格持续反弹，农药品种弱势震荡2023-5-23 9:04:11
·年度营收仅2.61万元，亚虹医药董监高薪酬不应超过同行业平均水平2023-5-23 8:15:58
·医药生物行业周报：医药反弹，建议积极布局（中药、创新、AI、个股机会）2023-5-22 22:15:29
·国防军工行业跟踪周报：淡化人事与中调变量，舰船板块再起，弹药板块亮眼，军机/无人机板块多点开花2023-5-22 20:22:37
·医药生物行业周报：23省肝功生化集采结果落地，行业头部公司有望显著受益2023-5-22 20:05:00
·美安医药2022年年度权益分派实施方案为：每10股派4.60元2023-5-22 18:45:59
·医药生物行业周报：医用耗材支付管理升级，关注相关投资机会2023-5-22 18:41:28
·科源制药上市仅月余三高层蹊跷离职营收扣非双失速研发支出三年降13%2023-5-22 17:50:35
·诺康达业绩异常波动涉嫌配合IPO调节仿制药收入占比60%研发费率两连降2023-5-22 17:42:11
·医药生物行业周报：全国中成药集采文件颁布，整体进度和规则符合预期2023-5-22 17:29:49
·5月22日康弘药业涨停分析：眼科，创新药，医药概念热股2023-5-22 16:57:14
·中药行业周报：基药目录调整或将提速，中药有望迎来院端放量2023-5-22 16:27:52
·科源制药上市仅月余三高层蹊跷离职营收扣非双失速研发支出三年降13%2023-5-22 11:12:38
·兴齐眼药（300573）5月19日主力资金净卖出241.15万元2023-5-22 10:13:41
·携手基层医疗卫生机构医生国产新冠创新药先诺欣真实世界研究项目启动2023-5-22 9:56:08
·诺思兰德：眼科药业绩快速稳步增长生物创新药开发与产业化进程加速2023-5-22 8:40:35

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]